---
module: 043-02
language: en
chapter: 43
title: "Ageing, Frailty, Polypharmacy, and Geriatric Assessment"
module_title: "Physiological reserve, medication burden, function, and goal-concordant ageing care"
source_sha256: 5ad9f95c96b9591d3ef18920f29e2510fb8f11de82a6efa6b1609a30c335576d
---
# Reserve, medication burden, function, and goals

## Narrowed reserve and presentation
### Normal resting values, narrowed reserve
#### Acute illness crosses several thresholds
### Falls, confusion, immobility, new dependence
### Baseline function as a diagnostic vital sign

## Frailty and function
### Reduced reserve and impaired recovery
#### Distinct from age, comorbidity, disability
### Scores estimate population risk only
### Contributors are modifiable
### Minor insult triggers dependence cascade
#### Prevent with early mobilisation from day one
### Ask specifically, not just "independent"
### Destination follows trajectory and goals

## Sarcopenia
### Low strength with reduced quantity or quality
### Grip, chair rise, gait speed reveal more
### Progressively loaded resistance exercise
### Protein cannot rebuild without mechanical load

## Cardiovascular ageing and orthostasis
### Stiffness, afterload, diastolic filling
### Reduced beta response limits compensation
### Many factors combine into orthostatic hypotension
### Measure after rest, several minutes standing
### Heart-rate response separates causes
#### Neurogenic: small heart-rate rise
#### Volume depletion: larger rise
### Symptom diary matches treatment to conditions

## Kidney and drug handling
### Low muscle mass overestimates filtration
#### Trends, cystatin, measured clearance
### Less reserve for water, sodium, potassium
### Water-soluble loading dose gives higher level
### Pharmacodynamics often outweigh kinetics
#### Delirium, falls, hypoglycaemia, bleeding

## Reconciliation and deprescribing
### Ask what is actually taken
### Cascade: new drug treats earlier adverse effect
### Deprescribing as a monitored therapeutic trial
#### Prioritise duplicates, toxicity, no indication
#### Judge prevention by absolute benefit and time
### Abrupt cessation risks withdrawal or rebound
### Change in stages with baseline values
### Success measured by function, not count

## Falls as events with mechanisms
### Ask before, during, and after
### Causes can coexist
### Treat identified contributors
### Inability to rise predicts harm
#### Pressure injury, rhabdomyolysis, hypothermia
### Walking does not exclude fracture
### Not simply a mechanical fall
### Graded return avoids disuse

## Delirium and comprehensive assessment
### Acute network dysfunction in vulnerable host
#### Dementia does not explain acute decline
#### Quiet patient may have hypoactive delirium
### Remove causes, rebuild orientation and cues
### Assessment converts problems into one plan
#### Effective only when implemented and owned

## Nutrition and continence
### Weight loss as disease and function
### Texture modification can reduce intake
### Albumin reflects inflammation and illness
### Continence depends on access and assistance
### Anticholinergics worsen cognition and falls
### Catheters need indication and removal plan

## Capacity and goal-concordant care
### Specific decision at a specific time
### Barriers can falsely appear as incapacity
### Record decision, options, own-words understanding
### Capacity is not all or nothing
### Substitute acts on the person's values
### Best, worst, most likely functional outcomes
### Proportionate care, not less care
### Plan ranks priority goal and reassessment
#### Palliation and rehabilitation used together
